← Back to Intel
Insider ActivityLENZ
Chevallard Daniel R., Chief Financial Officer at LENZ Therapeutics, Inc., bought $64K of LENZ
Updated Jun 11, 2026
Chevallard Daniel R.
Chief Financial Officer
LENZ Therapeutics, Inc. ·
$LENZ
Transaction Details
| Insider | Chevallard Daniel R. |
|---|---|
| Title | Chief Financial Officer |
| Company | LENZ Therapeutics, Inc. |
| Ticker | LENZ |
| Transaction Type | Purchase |
| Transaction Date | 2026-03-27 |
| Shares Traded | 7,500 |
| Price Per Share | $8.57 |
| Total Value | $64K |
| Filed Date | 2026-03-30 |
| Accession Number | 0001706176-26-000004 |
Ownership Context
| Shares Owned After Transaction | 12,886 |
|---|---|
| Ownership Type | Direct |
SEC Filing
Accession: 0001706176-26-000004
Other Insider Trades — LENZ
| Insider | Title | Action | Value | Date |
|---|---|---|---|---|
| Schimmelpennink Evert B. | President, CEO and Secretary, Director | bought | $251K | 2026-03-27 |
| George Jeffrey P. | Director | bought | $50K | 2026-03-27 |
Full Ticker Profile
View all insider trades, dark pool activity, congressional filings, and the Whisper Score for LENZ — LENZ Therapeutics, Inc. →
Track LENZ insider activity in real time on The Wire →
Get alerts when Chevallard Daniel R. files new trades — Go Pro →
Data sourced from SEC Form 4 insider trading filings. Transaction details are as reported to the Securities and Exchange Commission. This page does not constitute financial advice. StonkWhisper presents public records — it does not verify or guarantee the accuracy of SEC filings.
Last updated: June 11, 2026 at 07:23 UTC